Operator

Welcome to the 2026 Annual Stockholders Meeting for Dogwood Therapeutics, Inc. Our host for today's call is Greg Duncan, CEO and Chairman of the Board. [Operator Instructions] I'll now turn the call over to our host, Mr. Duncan, you may begin, sir.

Greg Duncan
Chairman & CEO

Good morning. I am Greg Duncan, and I have been appointed Chairman of today's meeting. I would like to express a sincere thank you on behalf of the entire Dogwood Therapeutics Board and our executive management team for your attendance at this year's meeting.

I now call the meeting to order. Angela Walsh, Chief Financial Officer and Treasurer of Dogwood will serve as the Secretary for today's meeting. I would also like to introduce Emily White of Equiniti Trust Company, who has been appointed as the Inspector of Elections for today's meeting. Ms. White has previously taken her oath as Inspector of Elections.

To start, I would like to introduce the current directors of the company. In addition to myself, the directors are Dr. Abel De La Rosa, Abel has served as an Independent Director since December 2020. David a.k.a. Rick Keefer. Rick has served as an Independent Director since 2018; John C. Thomas Jr., John has served as an Independent Director since December 2020. Dr. Melvin Toh, Melvin has served as a Director since October 2024. Dr. Richard Whitley, Rich has served as an Independent Director since December 2020.

And last but not least, Alan Yu. Alan has served as a Director since October 2024. Also in attendance today are representatives of FORVIS Mazars LLP, the company's independent registered public accounting firm.

Now